NewsRx

Search our medical news database

Angiotech Pharmaceuticals

Angiotech Pharmaceuticals officials detail recent developments

Published in Health Business Week, November 17th, 2006

Angiotech Pharmaceuticals officials detail recent developments.

This trend article is an immediate alert from NewsRx to identify the most recent news developments at Angiotech Pharmaceuticals.

Report 1: Angiotech Pharmaceuticals, Inc. (ANPI; TSX; ANP) announced positive preclinical data related to its Vascular Wrap paclitaxel-eluting mesh and Lifespan graft technology platform in hemodialysis patients.

Although synthetic grafts are currently used in approximately 40 percent of hemodialysis patients who require a permanent vascular access, primary patency rates remain poor. Most graft failures are caused by growth of scar tissue...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook